ATE543817T1 - Verfahren zur herstellung einer imidverbindung - Google Patents

Verfahren zur herstellung einer imidverbindung

Info

Publication number
ATE543817T1
ATE543817T1 AT04748182T AT04748182T ATE543817T1 AT E543817 T1 ATE543817 T1 AT E543817T1 AT 04748182 T AT04748182 T AT 04748182T AT 04748182 T AT04748182 T AT 04748182T AT E543817 T1 ATE543817 T1 AT E543817T1
Authority
AT
Austria
Prior art keywords
producing
imide compound
formula
compound hydrochloride
imide
Prior art date
Application number
AT04748182T
Other languages
English (en)
Inventor
Yuzo Kakiya
Mayumi Oda
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34100970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE543817(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE543817T1 publication Critical patent/ATE543817T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT04748182T 2003-07-29 2004-07-27 Verfahren zur herstellung einer imidverbindung ATE543817T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003281860 2003-07-29
PCT/JP2004/011035 WO2005009999A1 (ja) 2003-07-29 2004-07-27 イミド化合物の製造方法

Publications (1)

Publication Number Publication Date
ATE543817T1 true ATE543817T1 (de) 2012-02-15

Family

ID=34100970

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04748182T ATE543817T1 (de) 2003-07-29 2004-07-27 Verfahren zur herstellung einer imidverbindung

Country Status (12)

Country Link
US (2) US7605260B2 (de)
EP (1) EP1652848B1 (de)
JP (1) JP4610485B2 (de)
KR (1) KR101085806B1 (de)
CN (1) CN100422178C (de)
AT (1) ATE543817T1 (de)
AU (1) AU2004259305B2 (de)
BR (1) BRPI0413081B8 (de)
CA (1) CA2538265C (de)
DK (1) DK1652848T3 (de)
ES (1) ES2378990T3 (de)
WO (1) WO2005009999A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283352B2 (en) 2005-06-13 2012-10-09 Dainippon Sumitomo Pharma Co., Ltd. Solubilization preparation
CA2682494C (en) 2007-04-04 2011-10-11 Merck & Co., Inc. Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds for treating psychiatric disorders
WO2011093522A1 (en) * 2010-01-28 2011-08-04 Dainippon Sumitomo Pharma Co., Ltd. A cycloalkane derivative
ES2594709T3 (es) 2010-04-26 2016-12-22 Sumitomo Dainippon Pharma Co., Ltd. Un proceso de preparación de una sal de amonio cuaternario
EP2629775A4 (de) * 2010-10-18 2014-06-11 Dainippon Sumitomo Pharma Co Injizierbare formulierung mit verzögerter freisetzung
WO2012107890A2 (en) 2011-02-10 2012-08-16 Ranbaxy Laboratories Limited Crystalline forms of lurasidone hydrochloride
WO2012123858A1 (en) 2011-03-14 2012-09-20 Ranbaxy Laboratories Limited Amorphous lurasidone hydrochloride
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
CZ304027B6 (cs) * 2011-08-18 2013-08-28 Farmak, A. S. Zpusob prípravy polymorfu (1R,2S,3R,4S)-N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl]-1-cyklohexylmethyl]-2,3-bicyklo[2.2.1]heptandikarboximidu hydrochloridu
CN102952064A (zh) * 2011-08-19 2013-03-06 天津药物研究院 一种医药中间体顺式-外-二环[2.2.1]庚烷-2.3-二甲酰亚胺的制备方法
WO2013030722A1 (en) 2011-08-26 2013-03-07 Ranbaxy Laboratories Limited Crystalline lurasidone hydrochloride
CN103130794B (zh) * 2011-12-02 2016-06-22 苏州二叶制药有限公司 卢拉西酮盐酸盐的晶体a的制备方法
CN103130795A (zh) * 2011-12-02 2013-06-05 苏州二叶制药有限公司 卢拉西酮盐酸盐的晶体a及其用途
US9409899B2 (en) 2012-02-13 2016-08-09 Cadila Healthcare Limited Process for preparing benzisothiazol-3-yl-piperazin-1-yl-methyl-cyclo hexylmethanisoindol-1,3-dione and its intermediates
CN103360383B (zh) * 2012-04-11 2016-07-06 上海医药工业研究院 鲁拉西酮盐酸盐的晶型b及其制备方法
CN102746289B (zh) * 2012-04-28 2016-06-08 上海医药工业研究院 一种盐酸卢拉西酮的制备方法
WO2013190455A2 (en) * 2012-06-18 2013-12-27 Shasun Pharmaceuticals Limited Process for the preparation of lurasidone hydrochloride
CN102863437A (zh) * 2012-09-04 2013-01-09 济南百诺医药科技开发有限公司 一种鲁拉西酮的制备方法
WO2014064714A2 (en) * 2012-10-22 2014-05-01 Glenmark Pharmaceuticals Limited; Glenmark Generics Limited Process for preparation of lurasidone hydrochloride
CN102911170A (zh) * 2012-11-15 2013-02-06 苏州第壹制药有限公司 酰亚胺化合物盐酸盐的制备方法
CN105524057A (zh) * 2013-03-06 2016-04-27 江苏恩华药业股份有限公司 盐酸鲁拉西酮的新晶型及其制备方法
CN103539794A (zh) * 2013-10-17 2014-01-29 常州大学 一种盐酸鲁拉西酮的成盐方法
CZ306203B6 (cs) * 2013-12-06 2016-09-29 Zentiva, K. S Způsob syntézy lurasidonu
JP6594351B2 (ja) 2014-06-16 2019-10-23 ジョンソン、マッセイ、パブリック、リミテッド、カンパニー 新規中間体を含むアルキル化アリールピペラジン及びアルキル化アリールピペリジン化合物の製造方法
US10426770B2 (en) 2014-10-14 2019-10-01 Jubilant Generics Limited Process for the preparation of Lurasidone hydrochloride
CN111989102A (zh) 2018-02-28 2020-11-24 大日本住友制药株式会社 水性混悬液型药物制剂
JPWO2019167978A1 (ja) 2018-02-28 2021-02-04 大日本住友製薬株式会社 溶出が制御された水性懸濁型医薬製剤
CN113024535B (zh) 2019-12-24 2024-08-02 上海科胜药物研发有限公司 一种鲁拉西酮盐酸盐的制备方法
CN115950695B (zh) * 2021-10-09 2023-07-28 北京阳光诺和药物研究股份有限公司 一种制备鲁拉西酮基毒杂质的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS517440A (de) * 1974-07-08 1976-01-21 Japan Storage Battery Co Ltd
JPS57197265A (en) 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same
AU615966B2 (en) 1987-12-04 1991-10-17 Takeda Chemical Industries Ltd. Crystals of cephem hydrochloride
JP2800953B2 (ja) 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5663381A (en) * 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
DK1254092T3 (da) 2000-02-11 2004-03-15 Degussa Resolvering af DL-racemiske blandinger
AU2001246861A1 (en) * 2000-04-10 2001-10-23 Sumitomo Pharmaceuticals Co. Ltd. Sustained release preparations
CA2431041A1 (en) * 2001-01-02 2002-07-11 Pharmacia & Upjohn Company New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents

Also Published As

Publication number Publication date
JPWO2005009999A1 (ja) 2006-09-07
BRPI0413081B1 (pt) 2018-03-20
DK1652848T3 (da) 2012-02-27
EP1652848A1 (de) 2006-05-03
CN1832946A (zh) 2006-09-13
KR101085806B1 (ko) 2011-11-22
CA2538265A1 (en) 2005-02-03
AU2004259305B2 (en) 2009-06-04
JP4610485B2 (ja) 2011-01-12
BRPI0413081A (pt) 2006-10-03
CN100422178C (zh) 2008-10-01
CA2538265C (en) 2012-10-02
EP1652848B1 (de) 2012-02-01
US7605260B2 (en) 2009-10-20
WO2005009999A1 (ja) 2005-02-03
ES2378990T3 (es) 2012-04-19
EP1652848A4 (de) 2009-04-15
USRE45573E1 (en) 2015-06-23
AU2004259305A1 (en) 2005-02-03
US20060194970A1 (en) 2006-08-31
KR20060052840A (ko) 2006-05-19
BRPI0413081B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
ATE543817T1 (de) Verfahren zur herstellung einer imidverbindung
ATE445587T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i
ATE419239T1 (de) Verfahren zur herstellung von 4-phenoxy chinolin derivaten
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
ATE544744T1 (de) Verfahren zur herstellung von benzoesaure derivaten
EP1304316A4 (de) Verfahren zur herstellung von fluorierten organischen verbindungen und fluorierungsmittel
DE502005006163D1 (de) Verfahren zur herstellung quartärer ammoniumverbindungen hoher reinheit
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
ATE506346T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomet ylcyclopropan
DE60105141D1 (de) Verfahren zur Herstellung einer organischen Dünnschicht
EP1338596A4 (de) Verfahren zur herstellung antibakterieller verbindungen vom carbapenem-typ
ATE423764T1 (de) Verfahren zur herstellung von hydrazon-derivaten
ATE369357T1 (de) Verfahren zur herstellung von pantoprazol und seinen salzen
ATE480512T1 (de) Verfahren zur herstellung einer epoxytriazolverbindung und zwischenprodukt dafür
DE60223862D1 (de) Verfahren zur Herstellung von Terbinafine
ATE473966T1 (de) Verfahren zur herstellung eines carbonsäureamidderivats
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
DE50304869D1 (de) Verfahren zur herstellung einer spezifischen kristallmodifikation von 2-(2-chlor-4-mesyl-benzoyl)-cyclohexan-1,3-dion
ATE265421T1 (de) Verfahren zur herstellung von midodrin
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
ATE360006T1 (de) Verfahren zur racematspaltung von nefopam
DE60028998T8 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE510815T1 (de) Ein verfahren zur herstellung von sphingosin
ATE513835T1 (de) Verfahren zur herstellung von cefotetan
ATE501115T1 (de) Verfahren zur herstellung von entacapon